Direxion Daily S&P Biotec... (LABU)
AMEX: LABU
· Real-Time Price · USD
80.43
-0.77 (-0.95%)
At close: Sep 09, 2025, 3:59 PM
-0.95% (1D)
| Bid | 79.28 |
| Market Cap | 647.53M |
| AUM | 672.11M |
| NAV | 79.78 |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Shares Out | 8.05M |
| Inception Date | May 28, 2015 |
| Ask | 82.72 |
| Volume | 138.79K |
| Open | 81.50 |
| Previous Close | 81.20 |
| Day's Range | 80.38 - 81.79 |
| 52-Week Range | 32.55 - 152.58 |
| Holdings | 156 |
| Expense Ratio | 0.93% |
About LABU
The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, exchange-traded funds ("ETFs") that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
Asset Class Equity
Ticker Symbol LABU
Inception Date May 28, 2015
Provider Direxion
Website Fund Home Page
Exchange AMEX
Top 10 Holdings 5.32% of assets
| Name | Symbol | Weight |
|---|---|---|
| Alnylam Pharmaceutic... | ALNY | 0.64% |
| Insmed Incorporated | INSM | 0.62% |
| United Therapeutics ... | UTHR | 0.61% |
| Halozyme Therapeutic... | HALO | 0.58% |
| Incyte Corporation | INCY | 0.53% |
| Neurocrine Bioscienc... | NBIX | 0.49% |
| Abbvie Inc. | ABBV | 0.47% |
| Regeneron Pharmaceut... | REGN | 0.46% |
| Madrigal Pharmaceuti... | MDGL | 0.46% |
| Bridgebio Pharma, In... | BBIO | 0.46% |
Dividends Dividend Yield 0.55%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Jun 24, 2025 | $0.2190 | Jul 1, 2025 |
| Mar 25, 2025 | $0.1071 | Apr 1, 2025 |
| Jun 25, 2024 | $0.1502 | Jul 2, 2024 |
| Mar 19, 2024 | $0.1606 | Mar 26, 2024 |
| Dec 21, 2023 | $0.2097 | Dec 29, 2023 |
